Acadia Pharmaceuticals | L'Utile Ante Imposte



Pre Tax Profit Cambiamento Data
Acadia Pharmaceuticals USD 40.21M 12.43M 2025-06
ALKERMES USD 104.84M 79.35M 2025-06
Alnylam Pharmaceuticals USD -35358000 6.24M 2025-06
Biogen USD 744M 432.8M 2025-06
BioMarin Pharmaceutical USD 297.87M 59.78M 2025-06
Bristol-Myers Squibb USD 1.77B 1.2B 2025-06
Corcept Therapeutics USD 31.69M 22.07M 2025-06
Cytokinetics USD -134370000 27.01M 2025-06
Eisai JPY 22.4B 22.43B 2025-06
Eli Lilly USD 6.78B 3.32B 2025-06
Incyte USD 558.01M 323.82M 2025-06
J&J USD 13.63B 8.21B 2025-03
Moderna USD -818000000 146M 2025-06
Neurocrine Biosciences USD 159.5M 144.8M 2025-06
Pfizer USD 3.04B 259M 2025-06
Prothena USD -59501000 335K 2024-12
PTC Therapeutics USD -71052000 1B 2025-06
Sarepta Therapeutics USD 153.64M 537.16M 2025-06
Ultragenyx Pharmaceutical USD -114004000 35.77M 2025-06
Vertex Pharmaceuticals USD 1.28B 552.6M 2025-06


Acadia Pharmaceuticals L'Utile Ante Imposte - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.